{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : true,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P68036",
      "entity_text" : "UBE2L3",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:Q96P20",
      "entity_text" : "Nlrp3",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Treatment of Nlrp3 -/- and Asc -/- iBMDMs with ATP (XREF_FIG A) or nigericin (XREF_SUPPLEMENTARY F) did not deplete UBE2L3; similarly treated Casp1/4 -/- and Casp1 -/- iBMDMs retained UBE2L3 protein (XREF_FIG A, XREF_SUPPLEMENTARY F, and S1G).",
  "reading_complete" : "2020-08-08T09:56:29Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T09:54:00Z",
  "trigger" : "deplete",
  "evidence" : [ "Nlrp3 -/-  and Asc -/-  iBMDMs with ATP ( XREF_FIG A) or nigericin ( XREF_SUPPLEMENTARY F) did not deplete UBE2L3" ],
  "pmc_id" : "5300903",
  "score" : 0
}